Clinical Trial Results of Pollogen's TriPollar™ Radio

Frequency Technology published in the

Journal of the European Academy of Dermatology and
Venereology

TriPollar™ technology proven as an effective modality for immediate

and long term body contouring and circumference reduction

Tel Aviv, Israel May 21, 2009 – Clinical trial results using the regen™
system, the newest aesthetic solution powered by 3rd generation TriPollar RF
technology on cellulite treatment and body contouring, have been published in
the online Journal of the European Academy of Dermatology and
Venereology. The peer reviewed study, conducted by Dr. Manuskiatti et al. at
the Mahidol University Hospital, Bangkok entitled "Circumference reduction
and cellulite treatment with a TriPollar radiofrequency device: a pilot study"
was accept in February 2009, and is available online at
http://www3.interscience.wiley.com/journal/122312206/abstract

The study demonstrated long term measurable and durable body

circumference and fat thickness reduction using objective measurement
system (imaging Ultrasound). The study involved 37 patients treated once a
week with the regen system for a total of eight treatments. Results showed
that there was significant circumference reduction of 3.5 cm on average at the
abdomen with a maximum of 14.4 cm, and 1.71 cm reduction at the thigh
with a maximum of 9.1 cm. These results were maintained four weeks
following the last treatment. In addition, ultrasound measurements of the
distance between the epidermis and the superficial fascia showed an average
reduction of 10.5% in the thickness of adipose tissue with a maximum
reduction of 39% at the thigh region.

"TriPollar is a truly innovative technology that delivers what patients worldwide

have been waiting for- a pain free, safe and effective solution for body
contouring. The latest study clearly demonstrated that TriPollar RF
technology provides beneficial effects on the reduction of abdomen and thigh
circumferences and an overall improvement in the appearance of cellulite"
said Dr. Manuskiatti, lead investigator for Pollogen's clinical trial and
Associate Professor at the Department of Dermatology at the Siniraj Hospital,
Thailand.

Ms. Yfat Scialom, CEO of Pollogen commented: " The study show that the
innovative TriPollar RF technology, developed by Pollogen, delivers
consistent and effective results without pain and adverse side effects as
proven once again by the leading scientists and labs in the world. Our
customers worldwide are benefiting from the most advance RF technology
bringing safe, effective solution to a new standard. Since the launch of
Pollogen's professional anti-aging and body contouring products two years
ago, we have successfully captured the attention of physicians and
estheticians in over 50 countries world wide, and we look forward to
continued success in the future".

About Pollogen:
Pollogen Ltd. develops, manufactures and markets professional medical
aesthetic devices, powered by the TriPollar™ 3rd generation Radio
Frequency (RF) technology. Invented and perfected by Pollogen, proprietary
TriPollar™ technology powers a full line of clinically-proven, non-invasive and
non-surgical treatment platforms for wrinkles, cellulite, circumference
reduction and skin tightening. The flagship aesthetic devices, apollo™ and
regen™ offer customers clinically-proven, safe and effective anti-aging beauty
treatments that deliver immediate and long-lasting results. To learn more,
please visit the Pollogen website at www.pollogen.com

Contact:
Name: Abigail Marks
Tel: + 972-54-244-5807
E-mail: abigail_m@pollogen.com